Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serge Korjian, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
Beth Israel Deaconess Medical Center, BostonResidency Training06/2019Internal Medicine
Lebanese American University, Beirut, LebanonM.D.06/2014Medicine
2015 - 2016
Matthew Southard Scholar in Medicine

Overview

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gargiulo G, Cannon CP, Gibson CM, Goette A, Lopes RD, Oldgren J, Korjian S, Windecker S, Esposito G, Vranckx P, Valgimigli M. Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 09; 7(FI1):f50-f60. PMID: 33119069.
    Citations: 1     Fields:    
  2. Fabris E, Korjian S, Coller BS, Ten Berg JM, Granger CB, Gibson CM, van 't Hof AWJ. Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead. Thromb Haemost. 2021 Mar 07. PMID: 33677829.
    Citations:    Fields:    
  3. Korjian S, Dangas G, Gibson CM. Dual Antiplatelet Therapy Following PCI for NSTEMI: An Obvious Choice or a Calculated Decision? J Am Coll Cardiol. 2020 11 24; 76(21):2447-2449. PMID: 33213723.
    Citations:    Fields:    Translation:Humans
  4. Rao P, Diamond J, Korjian S, Martin L, Varghese M, Serfas JD, Lee R, Fraiche A, Kannam J, Reza N. The Impact of the COVID-19 Pandemic on Cardiovascular Fellows-in-Training: A National Survey. J Am Coll Cardiol. 2020 08 18; 76(7):871-875. PMID: 32561407.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  5. Mansour AG, Ahdab R, Daaboul Y, Korjian S, Morrison DA, Hariri E, Salem M, El Khoury C, Riachi N, Aoun Bahous S. Vitamin K2 Status and Arterial Stiffness Among Untreated Migraine Patients: A Case-Control Study. Headache. 2020 03; 60(3):589-599. PMID: 31769041.
    Citations: 1     Fields:    
  6. Yee MK, Gibson CM, Nafee T, Kerneis M, Daaboul Y, Korjian S, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Goldhaber SZ. Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial. TH Open. 2019 Apr; 3(2):e103-e108. PMID: 31249989.
    Citations: 1     
  7. Nafee T, Gibson CM, Yee MK, Kerneis M, Daaboul Y, Korjian S, Chi G, Kalayci A, Afzal MK, Kazmi H, Datta S, AlKhalfan F, Hernandez AF, Hull RD, Harrington RA, Cohen AT, Goldhaber SZ. Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. Circulation. 2019 02 26; 139(9):1234-1236. PMID: 30802169.
    Citations: 2     Fields:    Translation:Humans
  8. Gibson CM, Kerneis M, Yee MK, Daaboul Y, Korjian S, Mehr AP, Tricoci P, Alexander JH, Kastelein JJP, Mehran R, Bode C, Lewis BS, Mehta R, Duffy D, Feaster J, Halabi M, Angiolillo DJ, Duerschmied D, Ophuis TO, Merkely B. The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. Am Heart J. 2019 02; 208:81-90. PMID: 30580130.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  9. Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, Hull RD, Hernandez AF, Cohen AT, Harrington RA, Goldhaber SZ. Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial. Thromb Haemost. 2018 Dec; 118(12):2046-2052. PMID: 30419597.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  10. Korjian S, Daaboul Y, Laliberté F, Zhao Q, Mehran R, Bode C, Halperin J, Verheugt FWA, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM, Pinto DS. Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). Am J Cardiol. 2019 02 01; 123(3):355-360. PMID: 30502047.
    Citations: 1     Fields:    Translation:Humans
  11. Korjian S, Braunwald E, Daaboul Y, Mi M, Bhatt DL, Verheugt FWA, Cohen M, Bode C, Burton P, Plotnikov AN, Gibson CM. Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). Am J Cardiol. 2018 12 01; 122(11):1896-1901. PMID: 30340765.
    Citations: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  12. Daaboul Y, Korjian S, Plotnikov AN, Burton P, Braunwald E, Wiviott SD, Gibson CM. Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2018 03 06; 71(9):1048-1049. PMID: 29495985.
    Citations: 1     Fields:    Translation:Humans
  13. Hariri E, Mansour A, El Alam A, Daaboul Y, Korjian S, Aoun Bahous S. Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment. Int Urol Nephrol. 2018 Jun; 50(6):1075-1083. PMID: 29383580.
    Citations: 4     Fields:    Translation:Humans
  14. Gibson CM, Jennings LK, Chi G, Yee MK, Halaby R, Nafee T, AlKhalfan F, Kerneis M, Korjian S, Daaboul Y, Goldhaber SZ, Hull RD, Hernandez AF, Cohen AT, Harrington RA. Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial. TH Open. 2018 Jan; 2(1):e16-e24. PMID: 31249924.
    Citations: 1     
  15. Yee MK, Nafee T, Daaboul Y, Korjian S, AlKhalfan F, Kerneis M, Wiest C, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM. Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial. J Thromb Thrombolysis. 2018 Jan; 45(1):1-8. PMID: 29188425.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  16. Gibson CM, Nafee T, Yee MK, Chi G, Korjian S, Daaboul Y, AlKhalfan F, Kerneis M, Goldhaber SZ, Hull R, Hernandez AF, Cohen AT, Harrington RA. Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. Am Heart J. 2018 04; 198:84-90. PMID: 29653652.
    Citations: 4     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  17. Korjian S, Braunwald E, Daaboul Y, Verheugt F, Bode C, Tendera M, Jain P, Plotnikov A, Burton P, Gibson CM. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. Eur Heart J Acute Cardiovasc Care. 2019 Mar; 8(2):186-193. PMID: 29249166.
    Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  18. Chi G, Januzzi JL, Korjian S, Daaboul Y, Goldhaber SZ, Hernandez AF, Hull RD, Gold A, Cohen AT, Harrington RA, Gibson CM. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. J Thromb Thrombolysis. 2017 Nov; 44(4):457-465. PMID: 28905172.
    Citations: 3     Fields:    Translation:Humans
  19. Mansour AG, Hariri E, Daaboul Y, Korjian S, El Alam A, Protogerou AD, Kilany H, Karam A, Stephan A, Bahous SA. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial. J Am Soc Hypertens. 2017 Sep; 11(9):589-597. PMID: 28756183.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  20. Gibson CM, Korjian S, Chi G, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Lopes RD, Gold A, Cohen AT, Harrington RA. Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. J Am Heart Assoc. 2017 Jul 11; 6(7). PMID: 28698258.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  21. Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017 Jun; 1(1):e56-e65. PMID: 31249911.
    Citations: 21     
  22. Gibson CM, Korjian S. Collateral Circulation in Chronic Total Occlusions: A Marker of Hope or Hype? JACC Cardiovasc Interv. 2017 05 08; 10(9):915-917. PMID: 28473113.
    Citations: 1     Fields:    Translation:Humans
  23. Gibson CM, Goldhaber SZ, Cohen AT, Nafee T, Hernandez AF, Hull R, Korjian S, Daaboul Y, Chi G, Yee M, Harrington RA. When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials. Am Heart J. 2017 07; 189:1-8. PMID: 28625365.
    Citations: 2     Fields:    Translation:Humans
  24. Nafee T, Aslam A, Chi G, Pahlavani S, Nimri D, Kuchkuntla AR, Talib U, Michalak N, Daaboul Y, Korjian S, Gallo A, Gibson CM. Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors. Expert Rev Cardiovasc Ther. 2017 Apr; 15(4):237-245. PMID: 28282497.
    Citations: 2     Fields:    Translation:Humans
  25. El Ghoul B, Daaboul Y, Korjian S, El Alam A, Mansour A, Hariri E, Samad S, Salameh P, Dahdah G, Blacher J, Safar ME, Aoun Bahous S. Etiology of End-Stage Renal Disease and Arterial Stiffness among Hemodialysis Patients. Biomed Res Int. 2017; 2017:2543262. PMID: 28299320.
    Citations: 1     Fields:    Translation:Humans
  26. Yazbeck-Karam VG, Siddik-Sayyid SM, Barakat HB, Korjian S, Aouad MT. Haloperidol Versus Ondansetron for Treatment of Established Nausea and Vomiting Following General Anesthesia: A Randomized Clinical Trial. Anesth Analg. 2017 02; 124(2):438-444. PMID: 28002167.
    Citations: 3     Fields:    Translation:Humans
  27. Gibson CM, Halaby R, Korjian S, Daaboul Y, Arbetter DF, Yee MK, Goldhaber SZ, Hull R, Hernandez AF, Lu SP, Bandman O, Leeds JM, Gold A, Harrington RA, Cohen AT. The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J. 2017 Mar; 185:93-100. PMID: 28267480.
    Citations: 16     Fields:    Translation:Humans
  28. Abi Raad V, Raad K, Daaboul Y, Korjian S, Asmar N, Jammal M, Aoun Bahous S. Medical education in a foreign language and history-taking in the native language in Lebanon - a nationwide survey. BMC Med Educ. 2016 Nov 22; 16(1):298. PMID: 27876043.
    Citations: 4     Fields:    Translation:Humans
  29. Michael Gibson C, Korjian S, Tricoci P, Daaboul Y, Yee M, Jain P, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea DM, Deckelbaum LI, Merkely B, Zarebinski M, Ophuis TO, Harrington RA. Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I). Circulation. 2016 Dec 13; 134(24):1918-1930. PMID: 27881559.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  30. Gibson CM, Chi G, Halaby R, Korjian S, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Gold A, Bandman O, Harrington RA, Cohen AT. Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). Circulation. 2017 02 14; 135(7):648-655. PMID: 27881569.
    Citations: 18     Fields:    Translation:Humans
  31. Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, Korjian S, Daaboul Y, Lip GY, Cohen M, Husted S, Peterson ED, Fox KA. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016 12 22; 375(25):2423-2434. PMID: 27959713.
    Citations: 230     Fields:    Translation:Humans
  32. Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. 2017 Jan 24; 135(4):323-333. PMID: 27881555.
    Citations: 18     Fields:    Translation:Humans
  33. Gibson CM, Korjian S, Tricoci P, Daaboul Y, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea D, Merkely B, Zarebinski M, Ophius TO, Harrington RA. Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction. Am Heart J. 2016 Oct; 180:22-8. PMID: 27659879.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  34. Daaboul Y, Korjian S, Weaver WD, Kloner RA, Giugliano RP, Carr J, Neal BJ, Chi G, Cochet M, Goodell L, Michalak N, Rusowicz-Orazem L, Alkathery T, Allaham H, Routray S, Szlosek D, Jain P, Gibson CM. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Am J Cardiol. 2016 09 01; 118(5):625-31. PMID: 27392509.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  35. Korjian S, Daaboul Y, El-Ghoul B, Samad S, Salameh P, Dahdah G, Hariri E, Mansour A, Spielman K, Blacher J, Safar ME, Bahous SA. Change in Pulse Wave Velocity and Short-Term Development of Cardiovascular Events in the Hemodialysis Population. J Clin Hypertens (Greenwich). 2016 09; 18(9):857-63. PMID: 27226148.
    Citations:    Fields:    Translation:Humans
  36. Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ, White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW, Aylward PE, Strony J, Mahaffey KW, Gibson CM. Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy. Circ Cardiovasc Interv. 2016 May; 9(5):e003114. PMID: 27162212.
    Citations: 2     Fields:    Translation:HumansAnimals
  37. Gibson CM, Giugliano RP, Kloner RA, Bode C, Tendera M, Jánosi A, Merkely B, Godlewski J, Halaby R, Korjian S, Daaboul Y, Chakrabarti AK, Spielman K, Neal BJ, Weaver WD. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. Eur Heart J. 2016 Apr 21; 37(16):1296-303. PMID: 26586786.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  38. Korjian S, Daaboul Y, Halaby R, Goldhaber SZ, Cohen AT, Singh K, Susheela AT, Harrington RA, Hull RD, Hernandez AF, Gibson CM. Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need. J Cardiovasc Pharmacol Ther. 2016 05; 21(3):227-32. PMID: 26341120.
    Citations: 1     Fields:    Translation:Humans
  39. Daaboul Y, Korjian S, Khalil L, Nemr R. Pheochromocytoma Presenting as Partial HELLP Syndrome. Case Rep Obstet Gynecol. 2015; 2015:294326. PMID: 26351602.
    Citations:    
  40. Korjian S, Daaboul Y, Stephan A, Aoun Bahous S. Organ procurement: should we teach undergraduate medical and nursing students? Exp Clin Transplant. 2015 Apr; 13 Suppl 1:55-8. PMID: 25894128.
    Citations:    Fields:    Translation:Humans
  41. Bahous SA, Khairallah M, Al Danaf J, Halaby R, Korjian S, Daaboul Y, Salameh P, Stephan A, Blacher J, Safar ME. Renal function decline in recipients and donors of kidney grafts: role of aortic stiffness. Am J Nephrol. 2015; 41(1):57-65. PMID: 25662778.
    Citations: 5     Fields:    Translation:Humans
  42. Daaboul Y, Halaby R, Korjian S, Bahaa Eldin H, Lemor A, Singh K, Susheela AT, Ponnusamy V, Beereddy D, Hernández-Elenes JR, Poongkunran M, Ajari OW, Alvarado A, Gibson CM. Dual Pathway Therapy for Secondary Prevention Following Acute Coronary Syndrome. Current Cardiovascular Risk Reports. 2015; 5(9):1-7.
  43. Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM. D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan; 39(1):55-9. PMID: 25006010.
    Citations: 13     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Korjian's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (181)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.